Accessibility Menu
Conmed logo

Conmed(NYSE) CNMD

Market Cap$1.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1987)+2,682%
5 Year-65%
1 Year-9%
1 Month+41%
$46.41
-1.21%
-0.57Today
After hours$46.29-$0.12 (-0.26%)
Conmed last closing stock price
MetricPriceDate
Last closeUSD 46.302026-07-31
Conmed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.48%USD 42.682026-07-24
1 month+41.33%USD 32.762026-07-01
3 month+25.82%USD 36.802026-05-01
Year to date+14.04%USD 40.602025-12-31
1 year-9.14%USD 50.962025-07-31
3 year-59.84%USD 115.272023-08-01
5 year-65.08%USD 132.572021-07-30
Since inception+2,682.18%USD 1.661987-08-18

Conmed Financials at a Glance

Market Cap

$1.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.37B

Net Income (TTM)

$56.50M

EPS (TTM)

$1.85

P/E Ratio

25.04

Dividend

$0.20

Beta (Volatility)

1.09 (Average)

Price

$46.41

Volume

641,517

Open

$45.60

Previous Close

$46.30

Daily Range

$45.24 - $46.78

52-Week Range

$31.44 - $56.64

Estimated Earnings Date

Nov 4, 2026

CNMD News

Foolcom-Featured.png

Conmed (CNMD) Q2 EPS Jumps 17%

Motley Fool Markets TeamJul 31, 2025
directv satellite

3 Stocks Near 52-Week Highs Worth Selling

Sean WilliamsMay 15, 2014

CONMED Keeps Dividend Steady

Rich DupreyAug 27, 2013

CONMED Misses Where it Counts

Seth JaysonAug 1, 2013

Here's How CONMED Is Making So Much for You

Seth JaysonJul 11, 2013

Is CONMED Making You Fast Cash?

Seth JaysonJun 18, 2013

This Metric Says You're Smart to Own CONMED

Seth JaysonJun 11, 2013

Has CONMED Made You Any Real Money?

Seth JaysonMay 14, 2013
Page 1

CNMD: Motley Fool Moneyball Superscore

52

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Conmed

CONMED Corporation is a medical technology company focused on providing innovative surgical and patient care solutions. Its diverse product portfolio aims to enhance surgical outcomes and improve patient experiences through advanced technology.

Products and Services

Surgical Instruments: High-precision tools designed for various medical procedures.

Endoscopic Technologies: Products aiding minimally invasive surgeries.

Patient Care: Equipment and solutions for effective patient management.

Orthopedic Solutions: Devices targeting musculoskeletal conditions.

What Makes CONMED Corporation Special

CONMED Corporation differentiates itself through its commitment to innovation and adaptability. The company maintains a competitive edge by closely aligning its product development with the needs of healthcare professionals.

Five Things You Need to Know

CONMED has a strategic focus on surgical and patient care markets, leveraging advanced technology.

The company is noted for its diverse product offerings and commitment to high-quality, reliable innovations.

Leadership at CONMED emphasizes operational excellence and strategic acquisitions to enhance market standing.

Investment in research and development fuels product expansion and accommodates evolving healthcare needs.

CONMED aims for long-term growth by strengthening its presence in emerging markets and leveraging its strong distribution network.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,900

CEO

Patrick Joseph Beyer, MBA

Website

www.conmed.com

Headquarters

Largo, FL 33773-4908, US

CNMD Financials

Key Financial Metrics (TTM)

Gross Margin

54.80%

Operating Margin

10.79%

Net Income Margin

4.12%

Return on Equity

5.51%

Return on Capital

7.56%

Return on Assets

2.46%

Earnings Yield

3.99%

Dividend Yield

0.43%

Payout Ratio

21.91%

Stock Overview

Market Cap

$1.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.95M

Volume

641.52K

Avg. Volume

619.64K

Financials (TTM)

Gross Profit

$752.19M

Operating Income

$148.09M

EBITDA

$179.99M

Operating Cash Flow

$150.59M

Capital Expenditure

-$16.12M

Free Cash Flow

$134.46M

Cash & ST Invst.

$37.33M

Total Debt

$834.25M

Conmed Performance Analysis

Conmed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,030,387,0001.4%
20232023-12-31USD 1,240,954,00020.4%
20242024-12-31USD 1,302,730,0005.0%
20252025-12-31USD 1,374,495,0005.5%
Conmed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-1.3%
Q42025-12-3110.3%
Q12026-03-31-15.1%
Q22026-06-308.3%
Conmed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.68N/A
20232023-12-31USD 2.04N/A
20242024-12-31USD 4.25108.1%
20252025-12-31USD 1.51-64.5%
Conmed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-86.7%
Q42025-12-31486.3%
Q12026-03-31-16.7%
Q22026-06-3071.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$343.49M

+0.1%

Gross Profit

$197.46M

+9.4%

Gross Margin

57.49%

N/A

Market Cap

$1.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$355.57K

N/A

Employees

3,900

N/A

Net Income

$23.07M

+7.7%

EBITDA

$61.28M

+20.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$37.33M

+10.0%

Total Debt

$834.25M

-5.4%

Accounts Receivable

$239.77M

+2.4%

Inventory

$360.18M

-0.6%

Long Term Debt

$657.05M

-25.4%

Short Term Debt

$177.20M

+24717.8%

Return on Assets

2.46%

N/A

Return on Invested Capital

8.03%

N/A

Free Cash Flow

$34.16M

+46.0%

Operating Cash Flow

$37.10M

+27.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KMTSKestra Medical Technologies, Ltd.
$22.83-1.38%
AHCOAdaptHealth Corp.
$10.80+1.12%
AZTAAzenta, Inc.
$28.13-2.33%
NTLAIntellia Therapeutics, Inc.
$10.68-3.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About CNMD

What is the current price of Conmed?

Conmed is trading at $46.30 per share.

What is the 52-week range for Conmed?

Over the past 52 weeks, Conmed has traded between $31.44 and $56.64.

How much debt does Conmed have?

As of the most recent reporting period, Conmed reported total debt of $834.25M.

How much cash does Conmed have on hand?

Conmed reported $37.33M in cash and cash equivalents in its most recent financial results.

What is Conmed’s dividend yield?

Conmed currently has a dividend yield of 0.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services